Objective:To compare the clinical activity, survival and toxicity of IVP and CAP for advanced non small cell cancer(NSCLC)in aged.
目的对比IVP方案与CAP方案治疗老年晚期非小细胞肺癌的临床疗效、生存期及毒副反应。
Objective:To observe the efficacy and toxicity of domestic epirubicin in treatment of non Hodgkin's lymphoma, breast cancer, and non small cell lung cancer.
目的：观察国产表柔比星为主的联合化疗方案治疗非霍奇金淋巴瘤、乳腺癌、非小细胞肺癌的疗效和不良反应。
There are two major types: non-small cell lung cancer, which is the most common, and small cell lung cancer, which spreads more quickly.
有两种主要类型：最常见的是“非小细胞肺癌”；另一种是扩展非常迅速的“小细胞肺癌”。
The information was collected from people 65 and older who died from non-small-cell lung cancer between 1999 and 2003.
这些信息是从1999 - 2003年里65岁及以上因患非小细胞肺癌死亡的患者那里收集到的。
The TNM lung cancer staging system is primarily utilized for non-small-cell lung cancer (NSCLC), which accounts for approximately 75% of lung cancer diagnoses.
肺癌的TNM系统最初用于非小细胞癌(NSCLC)，这种癌大约占所有肺癌的75%。
Non-small-cell lung cancer grows more slowly and is more common, accounting for almost 90% of all lung cancers.
另外一种非小细胞癌，生长更慢些，也更为常见，90%的肺癌都是这种类型。
Pfizer’s crizotinib attacks a protein encoded by a gene found in fewer than 5% of patients with non-small-cell lung cancer.
辉瑞公司的crizotinib攻击某种蛋白质，这种蛋白质由在不到5%的非小细胞肺癌患者中发现的一种基因编码。
The cancer concerned, known rather cryptically as non-small-cell lung cancer, is actually the most common form of the disease, accounting for about 80% of cases.
而Bang研究的肺癌种类是并不是某些罕见的如非小细胞肺癌之类，而是最常见的种类，约80%的病例都是罹患这种肺癌。
Objective to investigate the expression of COX-2 and its relation to clinical pathophysiological features and prognosis in non-small cell lung cancer (NSCLC).
目的探讨非小细胞肺癌组织中COX 2的表达情况及其与患者临床病理生理特征和预后的关系。
Objective: To study the expression of KAI1/CD82 in non-small cell lung carcinomas (NSCLC) and explore the mechanism of invasion and metastasis of tumor cell.
目的：探讨KAI1/CD82 基因在非小细胞肺癌（NSCLC）组织中的表达水平及在癌细胞发生侵袭、转移过程中的意义。
Medical oncologists are faced with multiple factors to consider when staging a patient with suspected or confirmed non-small cell lung cancer (NSCLC).
肿瘤病学家在对可疑或确诊的非小细胞肺癌患者进行分期时要面临多方面因素的考量。
PURPOSE: To determine the epidemiology, pathology and patterns of care for patients with non-small cell lung cancer (NSCLC) in the United States.
目的：为了测定美国非小细胞肺癌患者的流行病学、病理学和治疗模式。
Background and objective Chemotherapy is very important in the treatment of advanced non-small cell lung cancer.
背景与目的化疗在晚期非小细胞肺癌的治疗中具有极为重要的作用。
Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
中国的非小细胞肺癌病人中吉非替尼敏感的表皮生长因子受体酪氨酸激酶区域的突变。
Objective to observe the efficacy, toxicity and survival of Taxotere and Cisplatin regimen in advanced non? - small cell lung cancer.
目的观察泰素蒂加顺铂方案治疗进展期非小细胞肺癌的临床疗效、毒副作用。
Lung cancer is responsible for more deaths than any other cancer, with only 15% of patients reaching 5-year survival, and non-small cell lung cancer accounts for 75% of all lung cancer.
肺癌死亡率较其他肿瘤要高，只有15%的病人能达到五年存活期，而且非小细胞肺癌占所有肺部肿瘤的75%。
Clinical effect of radiotherapy combined with GP regimen chemotherapy in advanced non - small cell lung cancer.
放疗加gp方案化疗治疗中晚期非小细胞肺癌疗效观察。
Objective: to evaluate the clinical effect and toxicity of gemcitabine monotherapy in the treatment of elder advanced non-small cell lung cancer (NSCLC).
目的观察了解吉西他滨单药治疗老年晚期非小细胞肺癌(NSCLC)的临床疗效和毒性反应。
Objective it is to discuss the clinical significance of Kanglaite injection combined with chemotherapy on life quality improved in non-small cell lung cancer (NSCLC) patients in advanced stage.
目的探讨康莱特注射液联合化疗对晚期非小细胞肺癌(NSCLC)患者生活质量改善的临床意义。
Clinicopathologic Significance of the Mutations of the Epidermal Growth Factor Receptor Gene in Patients with Non-Small Cell Lung Cancer.
非小细胞肺癌病人的表皮生长因子受体基因突变的临床病理意义。
We hope that the adherence to these guidelines will standardize and improve preoperative and intraoperative LN staging and pathologic evaluation of non-small cell lung cancer.
我们希望我们所制定的指导规范能够使手术前和手术中淋巴结分期规范化，同时帮助提高非小细胞肺癌的病理诊断价值。
Cisplatin and continuous infusion homemade vinorelbine combination chemotherapy for advanced Non-small cell lung cancer.
持续静脉输注国产异长春花碱加顺铂治疗晚期非小细胞肺癌临床观察。
BACKGROUND: The aim of this study was to identify risk factors associated with survival after pneumonectomy for non-small cell lung cancer.
背景：该研究的目的是鉴别非小细胞肺癌患者全肺切除术治疗后与生存率相关的危险因子。
Objective to investigate the expression of WWOX protein in non-small cell lung cancer (NSCLC), and to analyse its correlation with the clinicopathological features of NSCLC.
目的观察非小细胞肺癌中包含氧化还原酶的ww域(WWOX)蛋白的表达，探讨其与临床病理参数的关系。
Objective To discuss the diagnostic value of detecting sulfate glycosaminoglycan fragments (SGF) in non-small cell lung cancer (NSCLC).
目的探讨血清硫酸粘多糖片段（SGF）检测在非小细胞肺癌（NSCLC）的诊断价值。
Objective To evaluate routine mediastinoscopy in detecting mediastinal lymph nodes status in patients with peripheral T1N0M0 non-small cell lung cancer (NSCLC).
目的探讨常规应用纵隔镜检查周围型T1N0M0非小细胞肺癌纵隔淋巴结转移情况。
Objective To evaluate routine mediastinoscopy in detecting mediastinal lymph nodes status in patients with peripheral T1N0M0 non-small cell lung cancer (NSCLC).
目的探讨常规应用纵隔镜检查周围型T1N0M0非小细胞肺癌纵隔淋巴结转移情况。
应用推荐